Rewriting the bioelectronic code to extend human life
The body runs on a bioelectronic code: a hidden language of electrical patterns that governs everything from wound healing to cancer growth.
At Coherence, we build therapeutic technology that reads and rewrites this code throughout the human body. Local modulation of the body’s bioelectronic signals allows for the monitoring and management of disease.
This is custom disease therapy, in real time.
The body is electric
Our bodies communicate both through chemicals like hormones and neurotransmitters and through electricity.
Tiny pulses of energy travel through nerves and tissues, orchestrating everything from your heartbeat to your thoughts. Neurons fire electrochemical impulses. The brain and nervous system function as complex, living circuits. Every sensation, movement, and emotion begins as an electrical signal.
This electrical activity forms the bioelectronic code — a language of patterns, frequencies, and pulses that governs how we function, feel, and heal.
Health and disease are not just chemical or genetic. They are also electrical.
When signals misfire or communication breaks down, illness can follow — from chronic pain and depression to autoimmune disorders, paralysis, and aggressive cancers like glioblastoma.
Cancer rewritten
Cancer isn’t just a genetic anomaly. It’s an active participant in the body’s electrical system.
Cancer monitors the body’s bioelectronic signals and responds with its own, hijacking the neural pathways used for healing and immune coordination to fuel its own growth.
At Coherence, we’re overwriting cancer’s bioelectronic signals.
The fourth pillar of cancer therapy
Cancer therapy has three pillars: drugs, radiotherapy, and surgery. We’re introducing a fourth pillar: electricity, via bioelectronic therapy. Bioelectronic therapy is divided into three primary modalities.
Targeted electrotherapy
Direct electrotherapy on malignant cells
.png)
Immunomodulation
Modulation of intrinsic immune function using electrical stimulation
.png)
Neuromodulation
Modulation of the supporting neural architecture that promotes disease
.png)
A new era in disease management
Coherence's products read the body’s electrical signals and deliver precise electrical modulation to areas affected by disease. This has the potential to slow disease progression, relieve symptoms, and supercharge immune support.
By bringing bioelectronic systems into stasis, we extend and improve quality of life.
Unlike chemotherapy or other systemic drugs, targeted bioelectronic therapy is localized. Electrically modulating aberrant bioelectrical signals offers a precise approach to treating disease while substantially minimizing side effects compared to conventional cancer treatment.
Targeted bioelectronic therapy shows promise across many conditions:
- Restoring movement after paralysis through spinal or brain stimulation
- Reversing stroke damage by reactivating dormant neural pathways
- Treating depression or PTSD by rebalancing malfunctioning brain circuits
- Boosting immunity or suppressing cancer by modulating nerve-to-immune signals
The Coherence platform
Our approach is built on three interconnected pillars:
Neurotechnology
We design implantable electronics capable of sensing and stimulating with unmatched precision. They’re small enough to fit on your fingertip, yet powerful enough to influence how the body behaves — without the side effects of systemic treatments.
Neurobiology
We are mapping how cancer communicates with the nervous system and learning how to intervene. In collaboration with our partners, we’re mapping this electrical dialogue and disrupting it — defining a new field of treatment: electro-oncology.
AI & Machine Learning
Our closed-loop systems learn from each patient in real time. Advanced AI decodes electrical signals to identify the unique fingerprint of each tumor, driving personalized therapy and building an unprecedented dataset on how cancer behaves in the body.
Glioma management
SOMA-1 is our flagship device: a minimally invasive, MRI-safe brain–computer interface implanted during existing neurosurgery. SOMA-1 both monitors and treats brain disorders like gliomas in real time.
- Closed-loop stimulation reduces disease burden as it evolves.
- Continuous recording tracks tumor behavior without repeated scans.
- Adaptive AI personalizes therapy based on live data from the tumor environment.
SOMA-1 is therapy, diagnostics, and a living model — all in a device the size of a shirt button.
Glioma is a debilitating and incurable cancer of the brain. Glioblastoma, the most aggressive form of brain cancer has a life expectancy of only 14 months from diagnosis. In over 20 years, the standard of care in glioblastoma has remained unchanged. Over 300,000 people will be diagnosed with glioblastoma, this year.
Neurotechnology and BCI will have a profound impact in treating and managing these conditions. We're starting where we can have the highest impact, fastest.
A patient-first paradigm
Gone are the days of burdensome treatments — no more head shaving, messy gel applications, bulky headgear that overheats, or cumbersome equipment.
With SOMA, patients can maintain their appearances and focus on enjoying life.
Patients are augmented by a holistic therapeutic system — a button-sized therapeutic implant; a modern, minimalist wearable that sits comfortably on top of the ear; and a user-friendly app.
Our platform dramatically improves quality of life — allowing patients to live easier, healthier, longer, and more joyful lives.
.png)
Bioelectronic cancer management
By decoding the body's electrical language, we’re unlocking a new way to understand and treat disease.
- Smarter: Personalized, real-time therapy for each patient.
- Faster: Deployable across conditions without years of redevelopment.
- Deeper: Reaching the core bioelectrical mechanisms of disease.
Coherence is laying the foundation of electro-oncology.
Welcome to a new paradigm in medicine.
